Anti-venom Market
Anti-Venom Market Size, Share & Trends Analysis Report by Species (Snake, Scorpion, Spider, and Others), by Anti-Venom Type (Polyvalent Anti-Venom and Monovalent Anti-Venom), by Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, and Others), by End-User (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2025-2035)
Industry Outlook
Anti-venom market was valued at $1.2 billion in 2024 and is projected to reach $3.2 billion by 2035, growing at a CAGR of 8.9% during the forecast period (2025-2035). Anti-venom, often referred to as venom antiserum, is a type of drug used to treat the symptoms of venomous bites or stings from animals, such as snakes, spiders, scorpions, and some marine species, such as jellyfish or cone snails. According to the World Health Organization (WHO), in September 2023, an estimated 5.4 million people globally are bitten by snakes each year, with 1.8 to 2.7 million cases of envenoming.
Segmental Outlook
- Based on the species, the market is segmented into snake, scorpion, spider, and others.
- Based on the anti-venom type, the market is segmented into polyvalent anti-venom and monovalent anti-venom.
- Based on the mode of action, the market is segmented into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.
- Based on the end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
The Polyvalent Anti-Venom Sub-Segment is Anticipated to Hold a Considerable Share of the Global Anti-Venom Market
The combination of increased snakebite incidents, growing awareness, and improved product offerings has driven the fast growth of the polyvalent anti-venom market, owing to rising cases of snake bites, scorpion bites, spiders, and others. And active components of polyvalent snake antivenom include taipan antivenom, death adder antivenom, brown snake antivenom, and tiger snake antivenom. Even when the snake responsible for the envenomation is unknown and monovalent antivenom cannot be selected, polyvalent antivenoms can save the lives of victims. Polyvalent anti-venoms are the most used anti-venom medication owing to their evident benefits.
Global Anti-Venom Market Share By Anti-Venom Type, 2024 (%)
Regional Outlook
The global anti-venom market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors, including CroFab, Smithsonian, Rare Disease Therapeutics Inc., and others.
North America is Expected to Hold a Significant CAGR in the Global Anti-Venom Market
The North American anti-venom market is experiencing significant growth, driven by a combination of environmental, healthcare, and technological factors. The high rate of snakebites and other dangerous bites in the area, the growing public awareness of venomous bites, and growing technological improvements are some of the major factors anticipated to hold a considerable share of the market. In North America, the US is expected to play an important role in market development. According to a report by the Centers for Disease Control and Prevention (CDC) in June 2021, around 7,000 to 8,000 people in the US are bitten by venomous snakes per year. While the ambush from snake bites is rare, many people suffer from prolonged injuries, highlighting the need for effective treatment. The high frequency of snake bites has led to the increasing demand for anti-venom solutions, which contributes to the expansion of the market. Additionally, regulatory approval and strategic initiatives by major industry players are expected to further development. For instance, in March 2022, Operax, Inc. announced that the US Food and Drug Administration (FDA) gave a fast-track designation to Varpladib-Methyl ("oral vspledb") for treatment purposes.
Market Players Outlook
The major companies serving the global anti-venom market include CSL Ltd., VINS Bioproducts Ltd., Bharat Serums and Vaccines Ltd., Instituto Clodomiro Picado, Inosan Biopharma, and others. These market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
Recent Development
- In March 2024, the Union Health Secretary (Government of India) launched a National Action Plan for Prevention and Control of Snakebite Envenoming (NAP-SE) in India. A vision to reduce snakebite deaths by half by 2030, NAPSE provides a broad framework for states to develop their action plan for management, prevention, and control of snakebites through the ‘One Health’ approach.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global anti-venom market. Based on the availability of data, information related to new product launches and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Global Anti-Venom Market Sales Analysis – Species | Anti-Venom Type | Mode of Action | End User|($ Million)
1.1. Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.2. Market Snapshot
2. Market Overview and Insights
2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Anti-Venom Industry Trends
2.2.2. Market Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Market Drivers
3.1.1. Drivers For the Global Anti-Venom Market: Impact Analysis
3.2. Market Pain Points and Challenges
3.2.1. Restraints For the Global Anti-Venom Market: Impact Analysis
3.3. Market Opportunities
4. Competitive Landscape
4.1. Competitive Dashboard –Anti-Venom Market Revenue by Manufacturers
4.2. Key Company Analysis
4.2.1. Overview
4.2.2. Species Portfolio
4.2.3. Financial Analysis (Subject to Data Availability)
4.2.4. SWOT Analysis
4.2.5. Business Strategy
4.3. Top Winning Strategies by Market Players
4.3.1. Merger and Acquisition
4.3.2. Species Launch
4.3.3. Partnership And Collaboration
5. Global Anti-Venom Market by Species ($ Million)
5.1. Snake
5.2. Scorpion
5.3. Spider
5.4. Others (Marine animals, Insects)
6. Global Anti-Venom Market by Anti-Venom Type ($ Million)
6.1. Polyvalent Anti-venom
6.2. Monovalent Anti-venom
7. Global Anti-Venom Market by Mode of Action ($ Million)
7.1. Cytotoxic
7.2. Neurotoxic
7.3. Haemotoxic
7.4. Cardiotoxic
7.5. Myotoxic
7.6. Others (Phospholipase A2 (PLA2s), hemorrhagic metalloproteinases
8. Global Anti-Venom Market by End User ($ Million)
8.1. Hospitals
8.2. Clinics
8.3. Ambulatory Surgical Centers
9. Regional Analysis
9.1. North American Anti-Venom Market Sales Analysis – Species | Anti-venom Type | Mode of Action | End User| Country ($ Million)
9.1.1. United States
9.1.2. Canada
9.2. European Anti-Venom Market Sales Analysis – Species | Anti-venom Type | Mode of Action | End User| Country ($ Million)
9.2.1. UK
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. France
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Asia-Pacific Anti-Venom Market Sales Analysis – Species | Anti-venom Type | Mode of Action | End User| Country ($ Million)
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.3.4. India
9.3.5. Australia & New Zealand
9.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
9.3.7. Rest of Asia-Pacific
9.4. Rest of the World Anti-Venom Market Sales Analysis – Species | Anti-venom Type | Mode of Action | End User| Country ($ Million)
9.4.1. Latin America
9.4.2. Middle East and Africa
10. Company Profiles
10.1. Alomone Labs, Ltd.
10.2. Bharat Serums and Vaccines Ltd.
10.3. Boehringer Ingelheim International GmbH
10.4. BTG International Inc.
10.5. CSL Limited
10.6. Haffkine Bio-Pharmaceutical Corp Ltd.
10.7. Haffkine Bio-Pharmaceutical Corp. Ltd.
10.8. Incepta Pharmaceuticals Ltd.
10.9. Inosan Biopharma
10.10. Instituto Clodomiro Picado
10.11. LATOXAN
10.12. Medtoxin Venom Laboratories
10.13. Merck & Co., Inc.
10.14. MG Biologics
10.15. Pfizer Inc.
10.16. Premium Serums and Vaccines Pvt. Ltd
10.17. Rare Disease Therapeutics Inc.
10.18. Rare Disease Therapeutics, Inc.
10.19. Serum Institute of India
10.20. VINS BioSpeciess Ltd.
1. Global Anti-Venom Market Research And Analysis By Species, 2024-2035 ($ Million)
2. Global Snake Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
3. Global Scorpion Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
4. Global Spider Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
5. Global Other Species Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
6. Global Anti-Venom Market Research And Analysis By Anti-Venom Type, 2024-2035 ($ Million)
7. Global Polyvalent Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
8. Global Monovalent Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
9. Global Anti-Venom Market Research And Analysis By Mode of Action, 2024-2035 ($ Million)
10. Global Cytotoxic Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
11. Global Neurotoxic Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
12. Global Haemotoxic Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
13. Global Cardiotoxic Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
14. Global Myotoxic Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
15. Global Others Mode of Action Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
16. Global Anti-Venom Market Research And Analysis By End User, 2024-2035 ($ Million)
17. Global Anti-Venom For Hospitals Market Research And Analysis By Region, 2024-2035 ($ Million)
18. Global Anti-Venom For Clinics Market Research And Analysis By Region, 2024-2035 ($ Million)
19. Global Anti-Venom For Ambulatory Surgical Centers Market Research And Analysis By Region, 2024-2035 ($ Million)
20. Global Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
21. North American Anti-Venom Market Research And Analysis By Country, 2024-2035 ($ Million)
22. North American Anti-Venom Market Research And Analysis By Species, 2024-2035 ($ Million)
23. North American Anti-Venom Market Research And Analysis By Anti-Venom Type, 2024-2035 ($ Million)
24. North American Anti-Venom Market Research And Analysis By Mode of Action, 2024-2035 ($ Million)
25. North American Anti-Venom Market Research And Analysis By End User, 2024-2035 ($ Million)
26. European Anti-Venom Market Research And Analysis By Country, 2024-2035 ($ Million)
27. European Anti-Venom Market Research And Analysis By Species, 2024-2035 ($ Million)
28. European Anti-Venom Market Research And Analysis By Anti-Venom Type, 2024-2035 ($ Million)
29. European Anti-Venom Market Research And Analysis By Mode of Action, 2024-2035 ($ Million)
30. European Anti-Venom Market Research And Analysis By End User, 2024-2035 ($ Million)
31. Asia-Pacific Anti-Venom Market Research And Analysis By Country, 2024-2035 ($ Million)
32. Asia-Pacific Anti-Venom Market Research And Analysis By Species, 2024-2035 ($ Million)
33. Asia-Pacific Anti-Venom Market Research And Analysis By Anti-Venom Type, 2024-2035 ($ Million)
34. Asia-Pacific Anti-Venom Market Research And Analysis By Mode of Action, 2024-2035 ($ Million)
35. Asia-Pacific Anti-Venom Market Research And Analysis By End User, 2024-2035 ($ Million)
36. Rest Of The World Anti-Venom Market Research And Analysis By Region, 2024-2035 ($ Million)
37. Rest Of The World Anti-Venom Market Research And Analysis By Species, 2024-2035 ($ Million)
38. Rest Of The World Anti-Venom Market Research And Analysis By Anti-Venom Type, 2024-2035 ($ Million)
39. Rest Of The World Anti-Venom Market Research And Analysis By Mode of Action, 2024-2035 ($ Million)
40. Rest Of The World Anti-Venom Market Research And Analysis By End User, 2024-2035 ($ Million)
1. Global Anti-Venom Market Share By Species, 2024 Vs 2035 (%)
2. Global Snake Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
3. Global Scorpion Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
4. Global Spider Anti-Venom Share By Region, 2024 Vs 2035 (%)
5. Global Other Species Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
6. Global Anti-Venom Market Share By Anti-Venom Types, 2024 Vs 2035 (%)
7. Global Polyvalent Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
8. Global Monovalent Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
9. Global Anti-Venom Market Share By Modes Of Action, 2024 Vs 2035 (%)
10. Global Cytotoxic Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
11. Global Neurotoxic Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
12. Global Haemotoxic Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
13. Global Cardiotoxic Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
14. Global Myotoxic Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
15. Global Others Mode of Action Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
16. Global Anti-Venom Market Share By End Use, 2024 Vs 2035 (%)
17. Global Anti-Venom For Hospital Market Share By Region, 2024 Vs 2035 (%)
18. Global Anti-Venom For Clinics Market Share By Region, 2024 Vs 2035 (%)
19. Global Anti-Venom For Ambulatory Surgical Centers Market Share By Region, 2024 Vs 2035 (%)
20. Global Anti-Venom Market Share By Region, 2024 Vs 2035 (%)
21. US Anti-Venom Market Size, 2024-2035 ($ Million)
22. Canada Anti-Venom Market Size, 2024-2035 ($ Million)
23. UK Anti-Venom Market Size, 2024-2035 ($ Million)
24. France Anti-Venom Market Size, 2024-2035 ($ Million)
25. Germany Anti-Venom Market Size, 2024-2035 ($ Million)
26. Italy Anti-Venom Market Size, 2024-2035 ($ Million)
27. Spain Anti-Venom Market Size, 2024-2035 ($ Million)
28. Russia Anti-Venom Market Size, 2024-2035 ($ Million)
29. Rest of Europe Anti-Venom Market Size, 2024-2035 ($ Million)
30. India Anti-Venom Market Size, 2024-2035 ($ Million)
31. China Anti-Venom Market Size, 2024-2035 ($ Million)
32. Japan Anti-Venom Market Size, 2024-2035 ($ Million)
33. South Korea Anti-Venom Market Size, 2024-2035 ($ Million)
34. Australia And New Zealand Anti-Venom Market Size, 2024-2035 ($ Million)
35. ASEAN Anti-Venom Market Size, 2024-2035 ($ Million)
36. Rest Of Asia-Pacific Anti-Venom Market Size, 2024-2035 ($ Million)
37. Rest Of The World Anti-Venom Market Size, 2024-2035 ($ Million)
FAQS
The size of the Anti-Venom market in 2024 is estimated to be around $1.2 billion.
North America holds the largest share in the Anti-Venom market.
Leading players in the Anti-Venom market include CSL Ltd., VINS Bioproducts Ltd., Bharat Serums and Vaccines Ltd., Instituto Clodomiro Picado, Inosan Biopharma, and others.
Anti-Venom market is expected to grow at a CAGR of 8.9% from 2025 to 2035.
Rising cases of venomous bites, improved healthcare access, and advancements in antivenom production are key factors driving the Anti-Venom Market growth.